Cephasonics today announced the introduction of the cQUB-1 (cQuest Ultrasound Box-1), the first product in a new family of cQUB white-label ultrasound systems designed and manufactured by Cephasonics for purchase by companies to rebrand with their own brand name and model number.

The quality and resolution of X-ray images depends on the characteristics of the focal point, the area that is struck by electrons and from which the resulting X-rays are emitted. A new ASTM International standard will allow users to determine the effective focal spot size of an X-ray source.

The U.S. Food and Drug Administration (FDA) approved the Sorin Freedom Solo and Solo Smart stentless heart valves from Sorin Group Canada Inc. to replace a diseased, damaged or malfunctioning aortic heart valve.

The use of stents has improved management and outcomes of coronary artery disease, and clinical trials are attempting to prove the same will be true for superficial femoral artery disease. Randomized trials have shown favorable results for self-expanding nitinol stents compared with balloon angioplasty. A new report seeks to test this treatment in a real-world population of patients enrolled in an observational registry.

Subscribe Now